Copyright
©The Author(s) 2025.
World J Stem Cells. Apr 26, 2025; 17(4): 102421
Published online Apr 26, 2025. doi: 10.4252/wjsc.v17.i4.102421
Published online Apr 26, 2025. doi: 10.4252/wjsc.v17.i4.102421
Figure 6 Forest plot.
A: Number of tyrosine hydroxylase-positive cells in the substantia nigra; B: Mesenchymal stem cells-derived extracellular vesicles source subgroup for tyrosine hydroxylase-positive cells in the substantia nigra. CI: Confidence interval; BMSC: Bone marrow mesenchymal stem cell; HUCMSC: Human umbilical cord mesenchymal stem cell.
- Citation: Wang XS, Wang Y, Xu Y, Zhang SR, Zhang Y, Peng LL, Wu N, Ye JS. Effectiveness of mesenchymal stem cell-derived extracellular vesicles therapy for Parkinson’s disease: A systematic review of preclinical studies. World J Stem Cells 2025; 17(4): 102421
- URL: https://www.wjgnet.com/1948-0210/full/v17/i4/102421.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v17.i4.102421